When examining one or higher dimensional data, researchers frequently aim to identify individual subsets (clusters) of objects within the dataset. With high-dimensional data (>3 dimensions), the data become progressively more sparsly distributed in space.
This nanoparticle platform for electric field detection is the first inorganic platform to use both intensity and spectro-ratiometric (relative color change) readout for the determination of local electric fields in vitro, in vivo, and in situ.
Running chemotherapeutic drug screens on tumor biopsies ex vivo has the potential to increase patient survival by personally matching them to the drug which is the most effective against their particular tumor.
Researchers in Prof. Karen Parker's laboratory have discovered a biomarker that could enable an objective laboratory-based test for diagnosing autism spectrum disorders (ASD) and predicting the severity of a patient's symptoms.
Researchers at Stanford have developed new fluorescent sensors to detect and monitor gastrointestinal (GI) permeability. GI permeability can be correlated with the prognosis of GI disease, thus earlier detection may lead to better patient outcomes.
Stanford researchers in the Blau Lab have discovered that telomere length can be used as a biomarker for cardiomyopathy diagnosis and drug screening with cardiomyocytes.
Researchers at Stanford have developed methods to classify and treat MYC-driven hematopoietic cancers. The MYC oncogene drives the proliferation and survival of many hematopoietic cancers. These cancers are highly aggressive and do not respond to conventional chemotherapies.
High-grade serous ovarian cancer (HG-SOC) is the most lethal gynecologic malignancy, in large part because most patients present with late-stage disease and receive the same therapeutic regimen despite significant heterogeneity in disease and clinical response.
A team of Stanford researchers have identified a set of biomarkers that could be used to recognize patients with age-related declines in their immune function.
Stanford researchers have developed a non-invasive method of assessing chromosomal composition in human embryos at the blastocyst stage, thus potentially improving chances of success following in vitro fertilization (IVF).
Stanford researchers have developed methods for genetic and epigenetic diagnosis of embryos to determine those of which are more likely to be chromosomally normal and advance in development. This assessment method allows selection of healthier embryos for implantation.
Researchers at Stanford have developed the paperfuge- an ultra-low cost (20 cents), light weight (2g) field portable centrifuge (125,000 rpm; 30,000 g RCF) made out of paper that runs on human power.
Stanford researchers have developed a PCR-based method that detects disease-relevant, isotype-specific antibodies and can be used to diagnose allergy. Allergy is a prevalent immune hypersensitivity disease that affects more than 20% of the US population.
Researchers at the Solgaard Lab have demonstrated that light sheet fluorescence microscopy (LSFM) with structured and pivoting illumination enables fast image acquisition and improved image quality.
This invention describes the designing of biochemical probes for acid-fast bacteria detection. This probe will measure the presence of acid-fast bacteria in a biological matrix.